ArticleScientific reports2026
Various distribution of BMPs in different periosteal layers contributing to inconsistent osteoinductivity of DBM-based products.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Canonical and emerging regulatory mechanisms of tissue remodeling: shared principles across organs and therapeutic opportunities.Frontiers in immunology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
As a native carrier of bone morphogenetic proteins (BMPs), demineralized bone matrix (DBM) has excellent osteoinductivity and is commonly used in clinical repair of bone defects. However, commercially DBM-based products present different osteoinductive potential. The purpose of this study were to compare the quantity of BMPs in DBM preparations harvested from different periosteal layers, as well as to evaluate the extraction efficiency of guanidine and collagenase. Three cortical bone particals were harvested from outer 1/3 cortical layer, middle 1/3 cortical layer and inner 1/3 cortical layer of single femoral shaft and were partly demineralized. Proteins were extracted from each sample separately with guanidine and collagenase, and the amounts of BMP-2 and BMP-7 were determined using enzyme-linked immunosorbent assay. After demineralization, the amounts of BMP-2 and BMP-7 in DBM were greater than cortical particles (p < 0.001). In general, the content of BMP-7 varied linearly with the content of BMP-2 independent of extraction method and the outer 1/3 cortical layer contained highest level of BMP-2 and BMP-7, while the inner 1/3 cortical layer contained lowest level (p < 0.05). In terms of extraction efficiency, guanidine significantly increased the extractable content of BMPs in all samples compared to collagenase. The considerable increasing multiples of extraction efficiency of GuHCl for BMP-2 and BMP-7 ranged from 13.3 to 23.7 times and from 2.8 to 126 times, respectively. This variability of BMP-2 and BMP-7 resulting from origin of periosteal layer of long bone is a potential reason for inconsistent osteoinductivity of DBM-based products.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.